Dr. Catalona - Prostate Cancer, PSA Study, and Nerve Sparing Prostate Surgery

Please consider a donation to the URF

Click here
to watch video

Click here
to request newsletter

Click here to view
Update on Consent Forms

Click here to watch
Sen. Dole's gala greetings

What is Prostate Cancer?
Click here for information

Click here to sign up
for emails from the URF

The site for prostate cancer information
from Dr. William Catalona

Our goal is to provide information on the latest advances in prostate cancer treatment and information on the research and work of Dr. William J. Catalona, Medical Director of the Urological Research Foundation.

Dr. Catalona developed the PSA test as a screening test for prostate cancer. He, and his research collaborators, continue their important work.

The funds and energies of the Urological Research Foundation (URF) are directed to research for the prevention, detection, treatment and cure of the diseases of the prostate and most specifically, prostate cancer.

Early Treatment of Prostate Cancer

The Early Treatment of Prostate Cancer video was developed to explain the issues associated with the treatment of early prostate cancer. This video is for men who have been recently diagnosed with prostate cancer and are trying to weigh the various options.

Click here to watch the video.

Featured Articles

Dr. Catalona’s Recommended Guidelines for PSA Screening
PSA screening has proved useful in detecting prostate cancer early enough for life-saving treatment. But now PSA Velocity, free PSA and pro-PSA may be more important predicators of significant prostate cancer than the PSA level itself.
Read this article

Know Your Test: PSA Standardization Dilemma
In recent years, it has become evident that the same patient, who has more than one PSA test, can have different PSA results if the blood samples were sent to different
laboratories.

Now, we know these differences in reported values are due primarily to differences in the standardization of different PSA tests.
Read this article

Recent Additions

USA Today put the URF website at the top of its list for prostate cancer information saying, it is "one of the most informative and consumer-friendly sites."
Litigation Update: Dr. Catalona�s Views and Conclusions - by William J. Catalona, MD The legal battle lasting nearly five years between Washington University and Dr. William J. Catalona over ownership of blood and tissue samples came to at end at the U.S. Supreme Court when the Court declined to take the case.
Click here for the complete article.
Genetics of Prostate Cancer: What You Should Know; Why You Should Care - by Cecilia Lacks, PhD This article continues our coverage on new discoveries in the genetics of prostate cancer that continue to change the way researchers view the development of prostate cancer and on the important contributions of Dr. William Catalona and his collaborators.
Click here for the complete article.

Prostate Cancer Deaths Decline - American Cancer Society

More than 90% of all prostate cancers are discovered in the local and regional stages; the 5-year relative survival rate for patients whose tumors are diagnosed at these stages approaches 100%. According to the most recent data, relative 10-year survival is 93% and 15- year survival is 77%. The dramatic improvements in survival, particularly at 5 years, are partly attributable to earlier diagnosis and improvement in treatment. Modern methods of detection and treatment mean that prostate cancers are now found earlier and treated amore effectively. If a man is diagnosed this year, his outlook is likely to be better than the numbers reported above. Modern methods of finding and treating prostate cancer have led to a yearly drop in death rate from prostate cancer. Men treated today may have an even better outlook than the numbers above.

Click here for the complete article.

Opportunities to Participate in Research Studies

Northwestern Memorial Hospital and Dr. William Catalona offer opportunities to participate in research projects on the treatment and prevention of prostate cancer.

Presently, men can participate in Free Prostate Screenings, A Study in Prostate Cancer Prevention, and A Familial Prostate Cancer Screening Program.

Participation in these programs is at no cost. For more information on these programs including sign-up forms please: Click Here

Recent Questions

1.  Often the material about determining the incidence and severity of the side effects of a radical prostatectomy refers to the "experience" of the surgeon as the most important factor.

How does a prospective patient interpret "experience?"
Click here for answer.

2.  Is there any connection between using Viagra and PSA values?
Click here for answer.

3.  Do men with prostate cancer ever have radiation prior to a radical prostatectomy?
Click here for answer.

4.  What are your thoughts on the recent study linking multi-vitamin use to increased prostate cancer risk? I was under the impression that vitamin D and vitamin E were beneficial to those of us who have had RP surgery. Now I wonder if I should continue taking these supplements based on the results of this recent study.
Click here for answer.

Click here for a complete list of Questions & Answers

Contact Dr. Catalona

William J. Catalona, M.D.
Professor, Department of Urology
Northwestern University Feinberg School of Medicine
Director, Clinical Prostate Cancer Program
Robert H. Lurie Comprehensive Cancer Center
Northwestern Memorial Hospital
675 North St. Clair Street
Suite 20-150
Chicago, Illinois 60611

Phone: (312) 695-4471
FAX (312) 695-7030
To schedule surgery, please contact
Dr. Catalona at (312) 695-4471 or via email at
wcatalona@nmff.org or wcatalona@aol.com.
Scheduling a return appointment: (312) 695-8146
E-mail: wcatalona@nmff.org